The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Yes there is another tab next to the video, marked Q&A!
Has anybody found the posted questions replies
1801 is in ongoing trials, a deal has been done on 737 1802 is on hold until 1801 testing has been completed. What other news is there to report? Market sentiment is often impossible to understand. I am invested in GFM who published a spectacular RNS this morning and the price moved just 3%. . Utterly bizarre!!
*no news
Don’t buy your point on 737. The current position is better than when there was news.
Yes, it's 0.1% of the capital (rising to 0.2% in February). That's less than I hold. The idea that PH is short on SAR is unfounded and, frankly, ridiculous.
Yes, krusty I checked too. though, I dont think they are reported if under a certain threshold.
My previous comment was deleted in the PH shorting thread. There are no shorts currently open on SAR.
Can you tell me where to find the Q&A ? I'm just seeing the video presentation .
I think a lot here are a bit nieve to how the markets work. Of course PH the organisation could short SAR. They have hundreds if not thousands of clients. Are you all saying that they can't short any company that is a client in some way? They'd never get any clients if that was the case. Neither would any of the other big brokers, if it was a rule.
SAR are being shorted because 737 news has now been announced and it was lacklustre, to say the least.
IMO, there isnt any anticipated news, not even the end of 1a, that will stop the downward trajectory. RF get more shares in a couple of weeks and will need to be issued more at some point because they won't have got thier money back yet. IMO We'll be dilluted by 5 million shares by the time they are out.
I said at the end if last year, that 2024 is going to be tense. Some shareholders will wobble and a lot of name calling with happen here. Having said that, I will keep buying in small amounts down to my old average of 0.74p or 37p in today's money. If we go lower than that, I'm drawing a line under it and will just sit on my holding until near end of phase 2. I am prepared for a tough year though.
The recording and the Q&A have just been posted. I received an email just now.
This just received:-
https://www.investormeetcompany.com/meetings/agm-proceedings-2023-2
... and responding by answering the Q&A's they were left ... nearly a month now and development is complete so prey tell what prevents 5 guys from responding as per their promise to take onboard the criticism around communication at the AGM .....
I know that I have said many times that no news must be good news at the moment, as they must have continuing success (as we have not been told otherwise), but this is turning into a bit of a joke now... Someone is up to something - company not admitting something is actually wrong, the MMs 'playing' with the stock, or PH just not being up to the job... However, the bottom line is the languishing shareprice. This is that share that I have my largest holding in I believed in them when I invested several years ago, but I just need the company to step up and do more of what they admitted they were not doing enough of - advertising and showcasing us to the wider public, and doing it more publically.
The peelers are a shower of hunts.
Absolutely agree MarcusB, whilst AIM is like the wild west at times I don't believe PH could short SAR on the sly
Cheers laz
Tend to agree Leggster but we have been "trusting the science" for over a decade and the SP still languishes where it was over three years ago and despite the progress made with 1801 and 737.
The financing package, we are told, was "the best option" but the BoD has never explained why.
By the by the IR email address shown on the Website still ain't working. Wonderful and symptomatic
With the sp back at this level I'm looking to pick some more up cheap. Limit order in for another 5k.
Good luck with it Rayboy. I will buy a chunky amount end of this month/feb: Personally, I am not too concerned about a few quid here or there as I am anticipating that any positive news will lift the sp
We are alllocked in and waiting for some news to get out F…k from this
Um got £500 in dealing acc & got itchy fingers laz I'll leave til afternoon
Very wise Surfie - it is as if you knew! Anyway probably saved yourself a few quid - hope it doesn't rise too quickly for you!
Morning Chaps - having worked in the markets for many years previous, its my view that the house (PH) would not be in a position to short a stock, without telling the market that they act for.
Best.
*their